FREETOWN, Sierra Leone, November 17th,2026. SF Pharma today announced a distribution agreement with Continental Life Pharmaceuticals, a Sierra Leone distributor. Continental Life will handle last-mile sales of SALMAL 120, SF Pharma’s anti-malarial treatment, as well as other SF Pharma medicines, to pharmacies, clinics and hospitals across the country.
SALMAL 120 combines Artemether 20mg and Lumefantrine 120mg and is used to treat uncomplicated malaria. It is made specifically for the Sierra Leone market and is supplied as a six-tablet course, at a price communities can afford.
"Partnering with Continental Life offers us the distribution network we need to bring in timely, affordable, and life saving medicines for people across Sierra Leone." Alton Plager, President, SF Pharma
Malaria's Reach
Malaria remains one of the leading causes of illness and death in West Africa, espeically among the young. SF Pharma works with healthcare providers, pharmacies, clinics and NGOs to build reliable supply chains so treatment is available when people need it. The partnership with Continental Life extends that work to the final step, getting medicine from the warehouse to the counter.
“Continental Life is excited to partner with SF Pharma to bring affordable, reliable, and high quality drugs to the people of Sierra Leone” said [Name], President at Continental Life Pharmaceuticals.
About SF Pharma
SF Pharma was founded to make sure effective, affordable anti-malarial medicines reach every corner of Sierra Leone and the wider ECOWAS region. Its team of Sierra Leonean and Canadian professionals combines local knowledge with international pharmaceutical standards. Learn more at salonepharma.com..
About Continential Life Pharmaceuticals
.